Developing Viability Index for Machine Perfused Livers
ConditionLiver Cirrhoses
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMassachusetts General Hospital
Machine perfusion technology is nearing the point of rescuing discarded liver grafts in the hope of proving them to be or improving them to the point of being transplantable. However, there are no validated metrics to determine transplantability after machine perfusion. This study involves collecting biopsies from transplanted livers before and after implantation to correlate metabolite and gene expression with post-transplant function. This data will help develop a viability index for machine perfused livers.
Male or female 18-75 years of age.
Candidate for a deceased-donor liver allograft.
Seropositivity for HIV-1.
Massachusetts General Hospital
Lead sponsor
Brigham and Women's Hospital
Collaborator
Shriners Hospitals for Children
Collaborator